hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Prof. Guang-Wen Cao

    Vice President of Cancer Epidemiology Committee of China Anti-Cancer Association, Shanghai, China.

Speakers

  • Prof. Massimo Colombo

    Chairman of the EASL International Liver Foundation, Geneva, Switzerland.
    Director of the Liver Center, San Raffaele Hospital, Milan, Italy.

  • Prof. Stefano Cascinu

    Chair, Unit of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

  • Prof. Ho-Seong Han

    President of the Korean Study Group of Laparoscopic Liver Surgery, Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.

  • Prof. Guo-Ming Shi

    Professor, Zhongshan Hospital of Fudan University, Shanghai, China.

  • Prof. Xin-Rong Yang

    Professor, Zhongshan Hospital of Fudan University, Shanghai, China.

  • Prof. Feng Shen

    Professor, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.

  • Prof. Nan Li

    Professor, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.



    This webinar is based on the article Systemic therapy for advanced cholangiocarcinoma: new options on the horizon

Moments

Presentation

  • Welcome Speech from Editor-in-Chief
  • Discussion on Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon
  • Scholar's Interaction
  • Experts discussed "How to diagnose hepatitis B infection with HCC at an early stage and carry out active antiviral therapy to specifically reduce the incidence of HCC”
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties